4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-20-026615
EVP and CFO sold 11,050 shares at an average $50.59 ($559,034)
- EVP and CFO acquired 13,245 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ridloff Elena EVP and CFO | 2020-04-29 | Option exercise | +10,000 | $25.12 | $251,200 | 10,000 | D |
| Ridloff Elena EVP and CFO | 2020-04-29 | Sale | −10,000 | $50.74 | $507,353 | 0 | D |
| Ridloff Elena EVP and CFO | 2020-04-29 | Option exercise | +3,245 | 3,245 | D | ||
| Ridloff Elena EVP and CFO | 2020-04-30 | Sale | −1,050 | $49.22 | $51,681 | 2,195 | D |
| Derivatives | |||||||
| Ridloff Elena EVP and CFO | 2020-04-29 | Option exercise · Stock Option (Right to Buy) | −10,000 | 35,547 | D | ||
| Ridloff Elena EVP and CFO | 2020-04-29 | Option exercise · Restricted Stock Units | −3,245 | 9,736 | D | ||
| Open-market sales · 11,050 sh · avg $50.59 · $559,034 | |||||||
Loading xslF345X03/doc4.xml…